JPRN-jRCT2080220836未知3 期
An open-label study of TAK-536 in patients with grade III hypertension
适应症
试验速览
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1.Grade III hypertension, etc.
排除标准
- •1.Hypertensive emergency or renovascular hypertension
- •2.Cardiac disease, cerebrovascular disorder, vascular disease, or advanced hypertensive retinopathy
- •3.Hyperkalemia, etc.
研究者
相似试验
未知
3 期
Phase III double-blind study of TAK-536CCB in patients with grade I or II essential hypertensioHypertensionJPRN-jRCT2080221566TAKEDA PHARMACEUTICAL COMPANY LTD.
未知
3 期
Phase III long-term study of TAK-536CCB in patients with grade I or II essential hypertensioHypertensionJPRN-jRCT2080221586TAKEDA PHARMACEUTICAL COMPANY LTD.
未知
3 期
An open-label study of TAK-536 in hypertensive patients with renal disorderHypertensionJPRN-jRCT2080220835Takeda Pharmaceutical Company Limited40
未知
1 期
A Phase 1 study of TAK-385 in Patients With Androgen Deprivation Treatment-Naive Prostate CancerJPRN-jRCT2080222485TAKEDA PHARMACEUTICAL COMPANY LTD.43
未知
3 期
Open-label study of TAK-875Diabetes mellitusJPRN-jRCT2080221565TAKEDA PHARMACEUTICAL COMPANY LTD.